Primary Site >> Liver Cancer
Gene >> UGT1A9
| 1. | |||||||||||
| Journal: | Cancer Res. 1997 Jul 15;57(14):2979-85. | ||||||||||
| Title: | Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. | ||||||||||
| Author: | Strassburg, C P|Manns, M P|Tukey, R H | ||||||||||
| PMID: | 9230212 | ||||||||||
| 2. | |||||||||||
| Journal: | Gastroenterology. 2001 Nov;121(5):1136-44. | ||||||||||
| Title: | Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. | ||||||||||
| Author: | Vogel, A|Kneip, S|Barut, A|Ehmer, U|Tukey, R H|Manns, M P|Strassburg, C P | ||||||||||
| PMID: | 11677206 | ||||||||||
| 3. | |||||||||||
| Journal: | Hepatology. 2004 Apr;39(4):970-7. | ||||||||||
| Title: | Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. | ||||||||||
| Author: | Ehmer, Ursula|Vogel, Arndt|Schutte, Jan Karl|Krone, Britta|Manns, Michael P|Strassburg, Christian P | ||||||||||
| PMID: | 15057901 | ||||||||||
| 4. | |||||||||||
| Journal: | Gastroenterology. 2010 Nov;139(5):1699-710, 1710.e1-2. | ||||||||||
| Title: | Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach. | ||||||||||
| Author: | Kalthoff, Sandra|Ehmer, Ursula|Freiberg, Nicole|Manns, Michael P|Strassburg, Christian P | ||||||||||
| PMID: | 20600030 | ||||||||||
| 5. | |||||||||||
| Journal: | Invest New Drugs. 2011 Dec;29(6):1511-4. | ||||||||||
| Title: | Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinoma. | ||||||||||
| Author: | Gomo, Charline|Coriat, Romain|Faivre, Lionel|Mir, Olivier|Ropert, Stanislas|Billemont, Bertrand|Dauphin, Alain|Tod, Michel|Goldwasser, Francois|Blanchet, Benoit | ||||||||||
| PMID: | 20706860 | ||||||||||
| 6. | |||||||||||
| Journal: | Br J Clin Pharmacol. 2011 Aug;72(2):294-305. | ||||||||||
| Title: | Population pharmacokinetic analysis of sorafenib in patients with solid tumours. | ||||||||||
| Author: | Jain, Lokesh|Woo, Sukyung|Gardner, Erin R|Dahut, William L|Kohn, Elise C|Kummar, Shivaani|Mould, Diane R|Giaccone, Giuseppe|Yarchoan, Robert|Venitz, Jurgen|Figg, William D | ||||||||||
| PMID: | 21392074 | ||||||||||
| 7. | |||||||||||
| Journal: | Transplant Proc. 2011 Sep;43(7):2800-5. | ||||||||||
| Title: | Using sorafenib for recurrent hepatocellular carcinoma after liver transplantation--interactions between calcineurin inhibitor: two case reports. | ||||||||||
| Author: | Takahara, T|Nitta, H|Hasegawa, Y|Itou, N|Takahashi, M|Wakabayashi, G | ||||||||||
| PMID: | 21911167 | ||||||||||
| 8. | |||||||||||
| Journal: | Chemosphere. 2012 Oct;89(5):526-9. | ||||||||||
| Title: | Effect of aflatoxin B1 on UDP-glucuronosyltransferase mRNA expression in HepG2 cells. | ||||||||||
| Author: | Hanioka, Nobumitsu|Nonaka, Yuko|Saito, Keita|Negishi, Tomoe|Okamoto, Keinosuke|Kataoka, Hiroyuki|Narimatsu, Shizuo | ||||||||||
| PMID: | 22749127 | ||||||||||
| 9. | |||||||||||
| Journal: | Cancer. 2013 Jan 1;119(1):136-42. | ||||||||||
| Title: | Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma. | ||||||||||
| Author: | Lee, Joo Ho|Chung, Young-Hwa|Kim, Jeong A|Shim, Ju Hyun|Lee, Danbi|Lee, Han Chu|Shin, Eun-Soon|Yoon, Jung Hwan|Kim, Byung Ik|Bae, Si Hyun|Koh, Kwang Cheol|Park, Neung-Hwa | ||||||||||
| PMID: | 22736425 | ||||||||||
| 10. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2013 Jul;72(1):269-72. | ||||||||||
| Title: | Pharmacokinetic interaction between sorafenib and prednisolone in a patient with hepatocellular carcinoma. | ||||||||||
| Author: | Noda, Satoshi|Shioya, Makoto|Hira, Daiki|Fujiyama, Yoshihide|Morita, Shin-ya|Terada, Tomohiro | ||||||||||
| PMID: | 23673446 | ||||||||||
| 11. | |||||||||||
| Journal: | PLoS One. 2014 May 5;9(5):e96664. | ||||||||||
| Title: | Sorafenib metabolism is significantly altered in the liver tumor tissue of hepatocellular carcinoma patient. | ||||||||||
| Author: | Ye, Ling|Yang, Xiaoshan|Guo, Enshuang|Chen, Weiying|Lu, Linlin|Wang, Ying|Peng, Xiaojuan|Yan, Tongmeng|Zhou, Fuyan|Liu, Zhongqiu | ||||||||||
| PMID: | 24797816 | ||||||||||
| 12. | |||||||||||
| Journal: | Pharm Res. 2015 Mar;32(3):1141-57. | ||||||||||
| Title: | Significantly decreased and more variable expression of major CYPs and UGTs in liver microsomes prepared from HBV-positive human hepatocellular carcinoma and matched pericarcinomatous tissues determined using an isotope label-free UPLC-MS/MS method. | ||||||||||
| Author: | Yan, Tongmeng|Gao, Song|Peng, Xiaojuan|Shi, Jian|Xie, Cong|Li, Qiang|Lu, Linlin|Wang, Ying|Zhou, Fuyuan|Liu, Zhongqiu|Hu, Ming | ||||||||||
| PMID: | 25288013 | ||||||||||
| 13. | |||||||||||
| Journal: | PLoS One. 2015 May 26;10(5):e0127524. | ||||||||||
| Title: | Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients. | ||||||||||
| Author: | Lu, Linlin|Zhou, Juan|Shi, Jian|Peng, Xiao-juan|Qi, Xiao-xiao|Wang, Ying|Li, Fang-Yuan|Zhou, Fu-Yuan|Liu, Liang|Liu, Zhong-Qiu | ||||||||||
| PMID: | 26010150 | ||||||||||
| 14. | |||||||||||
| Journal: | Pharmacogenomics. 2016 Sep;17(14):1483-90. | ||||||||||
| Title: | Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity. | ||||||||||
| Author: | Bins, Sander|Lenting, Anne|El Bouazzaoui, Samira|van Doorn, Leni|Oomen-de Hoop, Esther|Eskens, Ferry Alm|van Schaik, Ron Hn|Mathijssen, Ron Hj | ||||||||||
| PMID: | 27533851 | ||||||||||
| 15. | |||||||||||
| Journal: | Liver Int. 2017 Sep;37(9):1345-1353. | ||||||||||
| Title: | UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population. | ||||||||||
| Author: | De Mattia, Elena|Cecchin, Erika|Polesel, Jerry|Lupo, Francesco|Tiribelli, Claudio|Crovatto, Marina|Buonadonna, Angela|Toffoli, Giuseppe | ||||||||||
| PMID: | 28294511 | ||||||||||